Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ARCTARGX

Arcturus Therapeutics Holdings Inc.

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ARCT

48/100

ARGX

80/100

Quality

Is it a profitable, well-run business?

ARCT

2.0/10

ARGX

8.2/10

Growth

Is the company growing?

ARCT

3.0/10

ARGX

10.0/10

Valuation

Is the price reasonable? (higher = cheaper)

ARCT

3.3/10

ARGX

4.1/10

Risk

How risky are the shares? (higher = lower risk)

ARCT

1.2/10

ARGX

7.7/10

Momentum

Is the share price trending up?

ARCT

4.7/10

ARGX

7.5/10

Financial strength

Is the balance sheet healthy?

ARCT

5.0/10

ARGX

9.0/10

The balanced view

Model-generated

Arcturus Therapeutics Holdings Inc.

This company has a mixed profile, with supportive analyst views, although the shares have been volatile.

Leads on: no single area

Best feature: analysts broadly positive (Target upside: 210.0%)

Watch out: shares can be volatile (Beta (vs. market): 2.48)

argenx SE

This company scores well across most areas, with solid growth and supportive analyst views, although its current valuation deserves attention.

Leads on: quality, growth, valuation, risk, momentum, financial strength

Best feature: solid growth (Revenue growth (FY): 89.6%)

Watch out: valuation may be demanding (DCF upside: -668.4%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.